A significant advance in cancer investigation is occurring with the use of nanobodies to reactivate dysfunctional p53. This vital malignant protector protein is frequently disabled in various kinds of tumors, resulting https://madbookmarks.com/story21987622/vhh-fragments-reactivate-the-p53-protein-new-promising-pathway-for-cancer-management